| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_97810a7b1f908113c498141ca351d7f6 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0007 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
| filingDate |
2018-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2019-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aef2561b7abcbaaf57cdc245d3eacc52 |
| publicationDate |
2019-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
RU-2679080-C1 |
| titleOfInvention |
Peptide and method of treatment of alzheimer's disease |
| abstract |
FIELD: biochemistry; medicine. n SUBSTANCE: invention relates to biochemistry and medicine and is a peptide of the HD[pS]GYEVHH formula, where the serine residue is phosphorylated. n EFFECT: this peptide is capable of forming a stable zinc-mediated intermolecular complex with the metal-binding domain of human beta-amyloid and is used to treat Alzheimer's disease. n 5 cl, 3 dwg, 3 ex |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2784319-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2784732-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2784746-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2785354-C1 |
| priorityDate |
2018-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |